How should I start enoxaparin (Lovenox) for a 89‑kg patient with paroxysmal atrial fibrillation after the heparin drip was stopped one hour ago?

Starting Enoxaparin After Heparin Discontinuation for Paroxysmal Atrial Fibrillation

For your 89 kg patient with paroxysmal atrial fibrillation, start enoxaparin 1 mg/kg (89 mg) subcutaneously every 12 hours now, one hour after stopping the heparin drip.

Dosing Regimen

The standard therapeutic anticoagulation dose for atrial fibrillation is 1 mg/kg subcutaneously every 12 hours 1, 2, 3. For your 89 kg patient, this equals 89 mg subcutaneously every 12 hours.

• No loading dose is needed when transitioning from heparin to enoxaparin for atrial fibrillation
• The first dose can be given immediately (1 hour after stopping heparin is sufficient)
• Continue this regimen until you transition to oral anticoagulation (warfarin or a DOAC)

Key Considerations Before Dosing

Check renal function immediately:

• If creatinine clearance (CrCl) <30 mL/min: reduce to 1 mg/kg once daily 1, 2, 3
• If CrCl is normal: proceed with standard twice-daily dosing
• Use the Cockcroft-Gault equation to calculate CrCl 3

Important caveat: The evidence provided focuses heavily on acute coronary syndromes rather than isolated atrial fibrillation. However, the dosing principles remain consistent across indications when therapeutic anticoagulation is required 1, 2, 3.

Transition Strategy

Do not switch back and forth between heparin and enoxaparin - this increases bleeding risk significantly 4, 5. Once you start enoxaparin, continue it until transitioning to oral anticoagulation.

Overlap with warfarin (if using):

• Start warfarin on the same day as enoxaparin
• Continue enoxaparin for minimum 5 days AND until INR ≥2.0 for at least 24 hours 3
• Target INR 2.0-3.0 6, 7

If using a DOAC instead:

• Start the DOAC when the next enoxaparin dose would be due
• No overlap needed

Monitoring

• No routine anti-Xa monitoring needed for standard dosing in patients with normal renal function 3
• Monitor platelet count if therapy extends beyond 5-7 days (risk of heparin-induced thrombocytopenia, though lower with enoxaparin than UFH) 8
• Reassess renal function if clinical status changes

Common Pitfalls to Avoid

1. Don't underdose: Prophylactic doses (40 mg daily or 30 mg twice daily) are insufficient for stroke prevention in atrial fibrillation 9
2. Don't forget renal adjustment: Enoxaparin accumulates in renal insufficiency - this is a critical safety issue 1, 2, 3
3. Don't delay starting oral anticoagulation: Begin warfarin or DOAC planning immediately, as enoxaparin is a bridge, not definitive therapy for chronic atrial fibrillation

Duration of Therapy

Continue enoxaparin only as a short-term bridge until oral anticoagulation is therapeutic. For paroxysmal atrial fibrillation, long-term anticoagulation decisions should be based on CHA₂DS₂-VASc score, not on whether the patient is currently in atrial fibrillation 6, 7.